Clinical Trial Update: Phase II Clinical Trial of OPS-2071 in the Treatment of Irritable Bowel Syndrome of Diarrhea Type [Phase 2]

View source ↗

Summary

Phase II trial of OPS-2071 for Irritable Bowel Syndrome with diarrhea type (IBS-D) has completed. The update does not report trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome Diarrhea Predominant

Drugs mentioned

• OPS-2071

Snippet

Sponsor: Otsuka Beijing Research Institute | Conditions: Irritable Bowel Syndrome of Diarrhea Type (IBS-D) | Phase 2 | Status: COMPLETED